UiPath (PATH) is back in focus after PLDT Inc. highlighted how the UiPath Platform cut manual workloads, sped up customer response times, and reshaped risk reviews using AI driven orchestration and automation tools.
UiPath shares trade at US$13.25 after a short term pullback, with the 30 day share price return down 19.16% and the 7 day move weaker again. Yet the 90 day share price return, up 28.52%, and the 1 year total shareholder return at 5.75% hint that momentum has cooled recently rather than disappeared.
Compare UiPath’s automation push with other enterprises harnessing AI agents and orchestration by scanning a curated set of 95 robotics and automation stocks now shaping how work gets done at scale.
UiPath now sits in a curious spot. Recent gains are still visible on the chart while the latest pullback raises a simple question: Is most of the easy upside gone, or is the market still underpricing this automation story based on current valuation?
Most Popular Narrative: 39% Undervalued
On the most followed view of UiPath, a fair value of $21.54 versus the recent $13.25 close suggests a wide valuation gap that keeps the AI automation thesis very much alive for long term holders weighing this pullback.
My original thesis for UiPath was that it could become one of the major beneficiaries of the second phase of the AI boom, where AI moves beyond generating answers and starts actually doing work. That thesis hasn’t disappeared. UiPath continues to build out its agentic automation platform, combining AI agents with its existing automation and orchestration capabilities.
See why 43 investors see UiPath as 38% undervalued.
Result: Fair Value of $21.54 (UNDERVALUED)
Still, two pressure points could quickly weaken that UiPath narrative if they worsen and slow customer adoption as giants like Microsoft and ServiceNow bundle rival automation into existing software stacks.
Find out about the key risks to this UiPath narrative.
Next Steps
See potential in the UiPath story, or feel the market is pricing it fairly and moving on? Act while the latest data is fresh and pressure test your own thesis against the 4 key rewards.
Looking for more investment ideas beyond UiPath?
If UiPath has sharpened your focus on where capital goes next, broaden your watchlist now so you do not miss the next opportunity hiding in plain sight.
- Target stability first and stress test your downside by scanning a 30 resilient stocks with low risk scores that screens for resilience when conditions change.
- Hunt for value where quality and price still line up by reviewing a curated 29 high quality undervalued stocks that filters for strong fundamentals.
- Build a stream of potential cash income by assessing a focused 7 dividend fortresses that highlights higher yield opportunities.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if UiPath might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
